Senate Amendment 1 to Senate Bill 194

152nd General Assembly (2023 - 2024)

Bill Progress

Passed 3/28/24
The General Assembly has ended, the current status is the final status.

Bill Details

3/28/24
This Amendment does the following: 1. It clarifies the requirement for training required prior to the first time a pharmacist initiates therapy under this Act. 2. It changes the language for the type of negative test required to make it a test that is approved by the U.S. FDA. 3. It clarifies the requirements for action to be taken if a patient tests positive and adds the requirement, if approved by the patient, to send the test results to a primary care provider if the patient has one.

Bill Text

View HTML View PDF
You may need to disable your browser's pop-up blocker to view linked documents.

Amendments

AmendmentStatusIntroduction DatePrimary SponsorView Details

Roll Calls

ChamberResultDateVote TypeYesNoNot VotingAbsentPDF

Actions History

DateAction

Legislation Detail Feeds